Personalized Oral Dissolvable Film (ODF) Delivery Systems

Publication ID: 24-11857557_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Personalized Oral Dissolvable Film (ODF) Delivery Systems,” Published Technical Disclosure No. 24-11857557_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857557_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,557.

Summary of the Inventive Concept

Next-generation oral dissolvable film technology enabling personalized, dynamic, and targeted delivery of vitamin D3, revolutionizing the way we manage vitamin D deficiency and overall health.

Background and Problem Solved

The original oral dissolvable film patent, while innovative, has limitations in terms of individualized dosing and release profiles. The new inventive concept addresses these limitations by integrating wearable sensors, cloud-based algorithms, and automated manufacturing modules to create customized ODFs tailored to a user's unique health metrics and environmental factors.

Detailed Description of the Inventive Concept

The inventive concept comprises a system for personalized ODF delivery, wherein a wearable sensor detects a user's vitamin D3 levels, and a cloud-based algorithm generates a customized ODF composition. An automated ODF manufacturing module then produces the customized ODF, which can be administered orally or transdermally. The ODF composition and release profile can be dynamically adjusted based on a user's individual health metrics, environmental factors, and other relevant data. This enables targeted delivery of vitamin D3 to specific areas of the body, such as the gut microbiome, and provides a more effective and efficient way to manage vitamin D deficiency.

Novelty and Inventive Step

The new claims introduce a paradigm shift in oral dissolvable film technology by integrating wearable sensors, cloud-based algorithms, and automated manufacturing modules to create personalized, dynamic, and targeted delivery of vitamin D3. This is a significant departure from the original patent, which focused on a standardized ODF composition and release profile.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different types of sensors, such as implantable or ingestible sensors, or the integration of additional health metrics, such as genetic data or medical history. The inventive concept could also be adapted for use with other active ingredients or therapeutic areas.

Potential Commercial Applications and Market

The personalized ODF delivery system has significant commercial potential in the healthcare and wellness industries, particularly in the areas of personalized medicine, nutrition, and preventative care. The target market includes individuals with vitamin D deficiency, as well as healthcare providers and wellness companies seeking to offer more effective and personalized solutions for their patients and customers.

Field of Art

Pharmaceutical drug delivery systems, specifically oral dissolvable film (ODF) technologies for vitamin and nutrient delivery, requiring expertise in pharmaceutical formulation, materials science, and biomedical engineering

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree in pharmaceutical sciences or bioengineering, familiar with drug delivery technologies, sensor integration, and personalized medicine approaches, with working knowledge of film formulation techniques and digital health platforms

Obviousness Rationale

A PHOSITA would recognize that integrating digital health technologies with existing ODF platforms represents a predictable evolution of personalized medicine. The core ODF technology from the source patent provides a foundational framework that naturally suggests enhancement through sensor-driven customization. The technical elements of detecting vitamin levels, algorithmically adjusting composition, and dynamically manufacturing films represent logical extensions of existing pharmaceutical delivery methodologies.

Obvious Combinations & Variations

Source Patent Element
Oral dissolvable film containing vitamin D3 with specific composition parameters
PTD Variation
Sensor-driven dynamic ODF composition with real-time health metric integration
Obviousness Reasoning
Known techniques in personalized medicine suggest using real-time physiological data to modulate drug delivery, representing a predictable application of existing technological capabilities
Source Patent Element
Enteral delivery method for vitamin D3 via dissolvable film
PTD Variation
Transdermal and targeted gut microbiome delivery approaches
Obviousness Reasoning
Alternative drug delivery routes are well-established in pharmaceutical sciences, and adapting ODF technology to different absorption mechanisms represents a routine design optimization
Source Patent Element
Standard ODF manufacturing process using specific polymers and solvents
PTD Variation
Automated manufacturing module with cloud-based algorithmic composition generation
Obviousness Reasoning
Digital manufacturing and algorithmic composition control are emerging standard practices in personalized medicine, representing an obvious technological progression
Source Patent Element
Vitamin D3 stabilization within oral dissolvable film matrix
PTD Variation
pH-sensitive biodegradable coating for targeted gut microbiome delivery
Obviousness Reasoning
Targeted drug delivery using responsive polymer coatings is a known technique in pharmaceutical formulation, representing a predictable technological enhancement
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857557 and the disclosed personalized oral dissolvable film technologies, a person of ordinary skill in the art would find the claimed variations obvious. The integration of sensor technologies, algorithmic composition generation, and targeted delivery mechanisms represent predictable extensions of existing oral dissolvable film methodologies, thereby rendering subsequent claims obvious and non-patentable under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,557
TitleOral dissolvable film containing vitamin D3